Market overview
The global endoluminal & bronchoscopy robots market is worth USD 976 mn in 2026 and is forecast to reach USD 4.7 bn by 2036, growing at a 17.0% CAGR. United States is the largest country market and Robotic bronchoscopy is the largest by procedure segment.
| Scope | Robotic catheter systems for navigating inside the lung, kidney and gut: robotic bronchoscopy for lung nodules and ureteroscopy platforms, with consoles, catheters and service. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 800 mn |
| Value 2026 | USD 976 mn |
| Value 2036 | USD 4.7 bn |
| CAGR 2026-2036 | 17.0% |
| Volume 2026 | 283 thousand procedures |
| Volume 2036 | 1,506 thousand procedures |
| Average price 2026 | USD 3,443 per procedure |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Endoluminal & Bronchoscopy Robots market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 976 mn |
| 2027 | USD 1.1 bn |
| 2028 | USD 1.3 bn |
| 2029 | USD 1.6 bn |
| 2030 | USD 1.8 bn |
| 2031 | USD 2.1 bn |
| 2032 | USD 2.5 bn |
| 2033 | USD 2.9 bn |
| 2034 | USD 3.4 bn |
| 2035 | USD 4.0 bn |
| 2036 | USD 4.7 bn |
Endoluminal & Bronchoscopy Robots market segmentation
By procedure
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Robotic bronchoscopy | 78.0% | 65.6% | USD 761 mn | 15.0% |
| Robotic ureteroscopy and kidney | 12.0% | 16.7% | USD 117 mn | 20.9% |
| Robotic gastrointestinal endoluminal | 10.0% | 17.7% | USD 98 mn | 23.9% |
By component
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Disposables and instruments | 44.0% | 52.5% | USD 429 mn | 19.1% |
| Systems | 38.0% | 29.4% | USD 371 mn | 14.0% |
| Service | 18.0% | 18.1% | USD 176 mn | 17.1% |
By guidance technology
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Shape-sensing | 42.0% | 44.0% | USD 410 mn | 17.6% |
| Electromagnetic navigation | 30.0% | 26.0% | USD 293 mn | 15.3% |
| Imaging-guided | 28.0% | 30.0% | USD 273 mn | 17.8% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 66.0% | 62.0% | USD 644 mn | 16.3% |
| Ambulatory and specialty centres | 20.0% | 24.0% | USD 195 mn | 19.1% |
| Cancer centres | 14.0% | 14.0% | USD 137 mn | 17.0% |
By business model
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Capital sales | 34.0% | 28.0% | USD 332 mn | 14.8% |
| Leasing and usage-based | 22.0% | 26.0% | USD 215 mn | 19.0% |
| Per-procedure disposables | 44.0% | 46.0% | USD 429 mn | 17.5% |
Top 25 countries for endoluminal & bronchoscopy robots by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 96.0% of 2026 revenue and the 25 countries below together hold 98.8%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 703 mn | 72.0% | USD 3.4 bn | 17.0% |
| 2 | China | USD 59 mn | 6.0% | USD 333 mn | 19.0% |
| 3 | Japan | USD 39 mn | 4.0% | USD 164 mn | 15.4% |
| 4 | Germany | USD 29 mn | 3.0% | USD 131 mn | 16.2% |
| 5 | United Kingdom | USD 24 mn | 2.5% | USD 113 mn | 16.5% |
| 6 | France | USD 20 mn | 2.0% | USD 84 mn | 15.8% |
| 7 | South Korea | USD 20 mn | 2.0% | USD 103 mn | 18.1% |
| 8 | Italy | USD 15 mn | 1.5% | USD 61 mn | 15.3% |
| 9 | Spain | USD 15 mn | 1.5% | USD 66 mn | 16.2% |
| 10 | Australia | USD 15 mn | 1.5% | USD 70 mn | 17.0% |
| 11 | Canada | USD 3.5 mn | 0.4% | USD 15 mn | 16.0% |
| 12 | Netherlands | USD 2.6 mn | 0.3% | USD 12 mn | 16.1% |
| 13 | Switzerland | USD 2.6 mn | 0.3% | USD 12 mn | 16.1% |
| 14 | Taiwan | USD 2.1 mn | 0.2% | USD 9.4 mn | 15.9% |
| 15 | Singapore | USD 2.1 mn | 0.2% | USD 12 mn | 19.0% |
| 16 | Israel | USD 1.8 mn | 0.2% | USD 7.5 mn | 15.6% |
| 17 | Saudi Arabia | USD 1.8 mn | 0.2% | USD 9.4 mn | 18.2% |
| 18 | Belgium | USD 1.8 mn | 0.2% | USD 7.5 mn | 15.6% |
| 19 | India | USD 1.8 mn | 0.2% | USD 12 mn | 20.9% |
| 20 | United Arab Emirates | USD 1.3 mn | 0.1% | USD 7.0 mn | 18.7% |
| 21 | Brazil | USD 1.3 mn | 0.1% | USD 7.0 mn | 18.7% |
| 22 | Sweden | USD 1.3 mn | 0.1% | USD 5.6 mn | 16.1% |
| 23 | Austria | USD 1.3 mn | 0.1% | USD 5.6 mn | 16.1% |
| 24 | Turkey | USD 1.3 mn | 0.1% | USD 7.0 mn | 18.7% |
| 25 | Denmark | USD 0.88 mn | 0.09% | USD 3.8 mn | 15.6% |
| Rest of world | USD 12 mn | 1.2% | USD 55 mn | 16.7% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Intuitive
- Johnson & Johnson MedTech
Group 2: Regional and specialist players
- Noah Medical
- Olympus
Group 3: Emerging and niche players
- EndoQuest Robotics
- Neptune Medical
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the endoluminal & bronchoscopy robots market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 17.0% is calculated from the resulting values.
The market is divided by procedure, by component, by guidance technology, by end user, by business model. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the endoluminal & bronchoscopy robots market?
The global endoluminal & bronchoscopy robots market is estimated at USD 800 mn in 2025 and USD 976 mn in 2026.
How fast will the endoluminal & bronchoscopy robots market grow?
It is forecast to reach USD 4.7 bn by 2036, a compound annual growth rate of 17.0% from 2026, an increase of USD 3.7 bn.
Which country is the largest market for endoluminal & bronchoscopy robots?
United States is the largest market by revenue at USD 703 mn in 2026, 72.0% of the global total. The three largest countries together hold 82.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 19.0% a year from 2026 to 2036.
Which endoluminal & bronchoscopy robots segment is largest?
In the by procedure split, Robotic bronchoscopy is the largest segment with 78.0% of 2026 revenue.
Who are the leading endoluminal & bronchoscopy robots companies?
Global leaders include Intuitive, Johnson & Johnson MedTech.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Comparator SourcingUSD 976 mn · 8.5% CAGR
- Digital Twins TechnologiesUSD 967 mn · 21.0% CAGR
- Oncology Biomarker Translation ServicesUSD 990 mn · 9.5% CAGR
- Biosafety CabinetUSD 958 mn · 7.0% CAGR
- Endoscopic Imaging Logistics And ServiceUSD 1.0 bn · 5.5% CAGR
- Hospital Capacity Management SolutionsUSD 1.0 bn · 11.0% CAGR
- Glioblastoma Treatment DrugsUSD 945 mn · 5.5% CAGR
- Robotic Catheterization SystemsUSD 944 mn · 15.0% CAGR
← Emergency Transfer Vacuum Mattress Endoscopic Closure Systems →